The PATIENTS Program Transforming Pharmaceutical R&D
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
The PATIENTS Program Transforming Pharmaceutical R&D
-
Narrado por:
-
De:
Join us on The Bridge as we welcome Chris Blanchette, Vice President of Clinical Data Science and Evidence at NovoNordisk. Together, we explore how the PATIENTS Program’s Going National Initiative is reshaping the way pharmaceutical companies engage patients in research.
The PATIENTS Going National Initiative is about sharing the PATIENTS Program’s recipe for evidence-based approach for patient and community engagement beyond Baltimore. Weplan to develop partnerships with new communities to replicate the authentic experience of the 10-Step Framework and co-develop health research to be more patient-centered.
Backed by the incredible support of sponsors like NovoNordisk, Bayer, and AstraZeneca, the PATIENTS Programis poised to revolutionize patient engagement.
Don’t miss this thought-provoking conversation aboutinnovation, inclusion, and impact in the healthcare landscape!
Visithttps://podcasters.spotify.com/pod/show/the-patients-program to stay updated onboth past and upcoming episodes.
To watch this episode and more, visit ourYouTube channel https://www.youtube.com/playlist?list=PLf5TFMW2PWhKdIEaP2F9xN213vrkTrv9_
Subscribe to our YouTube Channel https://bit.ly/SubscribetoourYouTubeChannel
Links
Website http://patients.umaryland.edu
Facebook https://www.facebook.com/PATIENTSProgram/
Twitter https://twitter.com/PatientsProgram
Instagram https://www.instagram.com/thepatientsprogram/
LinkedIn https://www.linkedin.com/company/the-patients-program